OrbiMed Advisors overview
Stories about OrbiMed Advisors
SCERS reveals $35m commitment
The commitment to OrbiMed Private Investments X was reported at Sacramento County Employees' Retirement System's latest board meeting.
KCERA commits $20m to private equity
Kern County Employees Retirement Association approved the commitment to a fund managed by OrbiMed Advisors.
Cathay Life Insurance commits $25m each to two OrbiMed Advisors funds
The Taiwan-based insurance company has backed two private equity funds.
OrbiMed Advisors raises $3.5bn
The New York-based healthcare investment firm has raised capital for three funds.
OrbiMed raises $551m for China and India healthcare
The healthcare-focused investment firm beat its $450m initial target.
OrbiMed closes sixth flagship fund on $950m
OrbiMed’s most recent investment was earlier this month when it participated in a $53 million Series B financing for ORIC Pharmaceuticals.
OrbiMed Advisors contact information
Offices
601 Lexington Avenue, 53rd Street, 54th Floor, New York, 10022, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Trey Block | Job titleChief Financial Officer | LocationNew York, United States | Email  --------- |
| Key ContactMr. Zack Mager | Job titleVice President, Investor Services | LocationNew York, United States | Email ------- |
| Key ContactMr. William Price | Job titleManaging Director, Business Development | LocationNew York, United States | Email ------- |
| Key ContactMs. Kerrie Swingle | Job titleDirector of Investor Services | LocationNew York, United States | Email ------ |
OrbiMed Advisors funds managed
Funds in market: 2
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size -------- | Open dateSep 2025 | Strategy ----- | |
Fund size --------- | Open dateSep 2025 | Strategy ----------- | |
Closed funds: 17
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ----- | Close dateOct 2023 | Strategy ------ | |
Fund size ------ | Close dateOct 2023 | Strategy ------ | |
Fund size ------- | Close dateMar 2021 | Strategy --------- | |
Stories that mention OrbiMed Advisors
Side Letter: Thoma Bravo's growth fund; PE's foundation fortitude; M2O's LP boss loss
Thoma Bravo's debut growth offering is nearing a final close. Plus: foundations remain fond of private equity despite macro headwinds and boutique placement firm M2O has lost another senior secondaries executive. Here's today's brief, for our valued subscribers only.
CalSTRS commits $3.9bn to PE
The US-based pension fund has made commitments across 23 funds.
PEI 300 2021: Immune response to covid
What pandemic? The industry’s 300 largest firms raised a record $2.25 trillion in fresh capital over the past five years.
Asian Development Bank confirms $75m in commitments
The Manila-based bank has backed an Asia focused fund.
Betting big on ‘healthy China’
Deregulation, industry consolidation and population pressure are driving capital into the country’s healthcare sector.
True North to take $200m stake in India hospital chain
Capital from the Mumbai-based firm will be used to expand the Kerala Institute of Medical Sciences in India and the Middle East.
LP Radar - October 2015
See the latest PE LP updates, including allocation changes and people moves.
DRI expects to launch Fund III later this year
The Toronto-based drug royalty-focused firm closed its second fund on $701m last year and has been investing at a quick pace.